AtriCure Sells 5,000 Shares: Insider Move or Pattern Worth Watching?
A senior executive at AtriCure recently sold 5,000 shares, prompting questions about what this insider move means for...
Before investing in 2023, it's vital to learn key concepts. Equip yourself with knowledge to ensure smart investment choices.
17,856 articlesA senior executive at AtriCure recently sold 5,000 shares, prompting questions about what this insider move means for...
Two tobacco giants show divergent paths over 10 years, with dividend income boosting returns for both. Here's what ha...
Micron Technology posted strong results, yet the stock slipped. This guide weighs whether micron's dip: great chance ...
As AI-driven gains fade in 2026, investors face a choice on covered call ETFs. This piece breaks down performance, ri...
Oil prices surged this week as markets faced renewed supply worries. The piece outlines practical ways americans can ...
A recently launched XRP-focused ETF aims to deliver 3% monthly income by selling XRP call options, blending crypto ex...
A 40-year-old Democrat who owns a fitness company focused on pregnant and postpartum women pulled off a tight victory...
Kharg Island, a key Iran oil export hub, is under the spotlight as geopolitical tensions heighten risk to energy flow...
Starbucks still faces investor headwinds as revenue grows slowly and profitability remains pressured. A closer look a...
LoanDepot posted a larger first-quarter loss as market volatility and thinner gain-on-sale margins weighed on revenue...
Investors are watching novavax (nvax) 2025 earnings closely as the company pivots its vaccine portfolio. This article...
Magnolia (MGY) is delivering a pivotal Q1 2026 performance that tests the durability of its business model. This arti...